Five-year trajectories of long-term benzodiazepine use by adolescents: Patient, provider, and medication factors

Psychiatric Services

Volumn 62, Issue 8, 2011, Pages 900-907

  Yeh, Hsueh Han ^a   Chen, Chuan Yu ^a,b   Fang, Shao You ^b   Chang, I Shou ^a   Wu, Erin Chia Hsuan ^c   Lin, Keh Ming ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILD PSYCHIATRY; DRUG FORMULATION; DRUG HALF LIFE; DRUG USE; EPILEPSY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRESCRIPTION; PSYCHOSIS; RETROSPECTIVE STUDY; RISK; SCHOOL CHILD; TREATMENT INDICATION;

EID: 79961121889     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.62.8.pss6208_0900     Document Type: Article

References (41)

1. Greenhill LL, Vitiello B, Riddle MA, et al: Review of safety assessment methods used in pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry 42:627-633, 2003 (Pubitemid 39625047)
2. Jensen PS, Bhatara VS, Vitiello B, et al: Psychoactive medication prescribing practices for US children: gaps between research and clinical practice. Journal of the American Academy of Child and Adolescent Psychiatry 38:557-565, 1999 (Pubitemid 29203471)
3. Bramble D: Annotation: the use of psychotropic medications in children: a British view. Journal of Child Psychology and Psychiatry 44:169-179, 2003
4. Martin A, Leslie D: Trends in psychotropic medication costs for children and adolescents, 1997-2000. Archives of Pediatrics and Adolescent Medicine 157:997-1004, 2003 (Pubitemid 37222096)
5. Schirm E, Tobi H, Zito JM, et al: Psychotropic medication in children: a study from the Netherlands. Pediatrics 108:e25, 2001
6. Zito JM, Safer DJ, dosReis S, et al: Trends in the prescribing of psychotropic medications to preschoolers. JAMA 283:1025-1030, 2000 (Pubitemid 30112216)
7. Zito JM, Safer DJ, dosReis S, et al: Psychotropic practice patterns for youth: a 10-year perspective. Archives of Pediatrics and Adolescent Medicine 157:17-25, 2003 (Pubitemid 36343413)
8. Pathak P, West D, Martin BC, et al: Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005. Psychiatric Services 61:123-129, 2010
9. American Academy of Child and Adolescent Psychiatry: Practice parameter on the use of psychotropic medication in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 48:961-973, 2009
10. Campbell M, Cueva JE: Psychopharmacology in child and adolescent psychiatry: a review of the past seven years: part II. Journal of the American Academy of Child and Adolescent Psychiatry 34:1262-1272, 1995
11. Safer DJ, Zito JM, DosReis S: Concomitant psychotropic medication for youths. American Journal of Psychiatry 160:438-449, 2003 (Pubitemid 41102118)
12. Tosyali MC, Greenhill LL: Child and adolescent psychopharmacology: important developmental issues. Pediatric Clinics of North America 45:1021-1035, 1998
13. Townsend L, Floersch J, Findling RL: Adolescent attitudes toward psychiatric medication: the utility of the drug attitude inventory. Journal of Child Psychology and Psychiatry 50:1523-1531, 2009
14. Acquaviva E, Legleye S, Auleley GR, et al: Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data. BMC Psychiatry 9:72, 2009
15. Bodkin JA: Emerging uses for high-potency benzodiazepines in psychotic disorders. Journal of Clinical Psychiatry 51(suppl):S41-S46, 1999
16. Mindell JA, Emslie G, Blumer J, et al: Pharmacologic management of insomnia in children and adolescents: consensus statement. Pediatrics 117:e1223-e1232, 2006 (Pubitemid 46071221)
17. Witek MW, Rojas V, Alonso C, et al: Review of benzodiazepine use in children and adolescents. Psychiatric Quarterly 76:283-296, 2005 (Pubitemid 40922161)
18. Younus M, Labellarte MJ: Insomnia in children: when are hypnotics indicated? Pediatric Drugs 4:391-403, 2002 (Pubitemid 34651928)
19. Massanari M, Novitsky J, Reinstein LJ: Paradoxical reactions in children associated with midazolam use during endoscopy. Clinical Pediatrics 36:681-684, 1997 (Pubitemid 27527875)
20. Birchley G: Opioid and benzodiazepine withdrawal syndromes in the pediatric intensive care unit: a review of recent literature. Critical Care Nursing 14:26-37, 2009
21. Ista E, van Dijk M, Gamel C, et al: Withdrawal symptoms in children after longterm administration of sedatives and/or analgesics: a literature review: assessment remains troublesome. Intensive Care Medicine 33:1396-1406, 2007 (Pubitemid 47101702)
22. Brunette MF, Noordsy DL, Xie H, et al: Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. Psychiatric Services 54:1395-1401, 2003 (Pubitemid 37220041)
23. Fang SY, Chen CY, Chang IS, et al: Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study. Drug and Alcohol Dependence 104:140-146, 2009
24. Hemmelgarn B, Suissa S, Huang A, et al: Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 278:27-31, 1997 (Pubitemid 27274512)
25. Van Hulten R, Teeuw KB, Bakker A, et al: Initial 3-month usage characteristics predict long-term use of benzodiazepines: an 8-year follow-up. European Journal of Clinical Pharmacology 58:689-694, 2003 (Pubitemid 36363298)
26. Chen CY, Liu CY, Su WC, et al: Factors associated with the diagnosis of neurodevelopmental disorders: a population-based longitudinal study. Pediatrics 119:e435-e443, 2007
27. Liu CY, Hung YT, Chuang YL, et al: Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. Journal of Health Management 4:1-22, 2006
28. Huang P: An overview of hospital accreditation in Taiwan, Republic of China. International Journal of Health Planning and Management 10:183-191, 1995
29. Huang P: Quality assurance in Taiwan, the Republic of China. International Journal for Quality in Health Care 8:75-82, 1996
30. Guidelines for Benzodiazepine Using in Sedation and Hypnosis. Department of Health, Food and Drug Administration, Executive Yuan, Taiwan. Available at www.fda.gov.tw/files/people-laws/ Guidelines%20for%20Benzodiazepine%20Using%20in%20Sedation%20and%20Hypnosis.pdf
31. Guidelines for ATC Classification and DDD Assignment. Oslo, Norway, World Health Organization, Collaborating Center for Drug Statistic Methodology, 2009
32. Jones BL, Nagin DS, Roeder K: A SAS procedure based on mixture models for estimating developmental trajectories. Sociological Methods and Research 29:374-393, 2001
33. Nagin DS: Analyzing developmental trajectories: a semiparametric, group based approach. Psychological Methods 4:139-157, 1999
34. Bauer DJ: Observations on the use of growth mixture models in psychological research. Multivariate Behavioral Research 42:757-786, 2007
35. Zandstra SM, Furer JW, van de Lisdonk EH, et al: Differences in health status between long-term and short-term benzodiazepine users. British Journal of General Practice 52:805-808, 2002
36. Piperidou C, Karlovasitou A, Triantafyllou N, et al: Association of demographic, clinical and treatment variables with quality of life of patients with epilepsy in Greece. Quality of Life Research 17:987-996, 2008
37. Barnett SR, Riddle MA: Anxiolytics: benzodiazepines, buspirone, and others; in Pediatric Psychopharmacology: Principles and Practice. Edited by Martin A, Scahill L, Charney D, et al. New York, Oxford University Press, 2003
38. Simon GE, VonKorff M, Barlow W, et al: Predictors of chronic benzodiazepine use in a health maintenance organization sample. Journal of Clinical Epidemiology 49:1067-1073, 1996 (Pubitemid 26319043)
39. Martyres RF, Clode D, Burns JM: Seeking drugs or seeking help? Escalating "doctor shopping" by young heroin users before fatal overdose. Medical Journal of Australia 180:211-214, 2004 (Pubitemid 38312981)
40. Veronese A, Garatti M, Cipriani A, et al: Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation. European Journal of Clinical Pharmacology 63:867-873, 2007 (Pubitemid 47237904)
41. Kurihara T: More rational use of benzodiazepines in the outpatient clinic. Internal Medicine 46:255-256, 2007